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Summary 
NKB1 is one member ofa ~owing family ofkiUer cell inhibitory receptms (K/R~.  It is ex- 
pressed on natural kilIer (NK) cells and T  cells, and has been showrt to inhibit cytolytic s 
tions of these cells upon interacting ~th  its hga~,, HLA-B (Bw4). We demongrate he_xe  that 
the cytoplasmic' region of NKB1 is capab~ of inhibiting T  cell, activation m jmrkat cdls. ~e 
ty~osme phosphorylation of the NKBI KtR consensus motif, YxxL(x)~YxxL, induces an amo- 
c/afion with the protein tyrosine phosphat~.se  1C (PTPIC). Im~rtantly, mutation of both ty- 
rosines in the motif a~ecl,  the inhibitory functions of NKB1 and ahrt~ted PTIrtC 
tion.  Mutational  analysis  of the  individual  tyrosines  suggest  that the  membrane  pro.xim~ 
tyrosine may play a crtrdal role in mediating the inh/bitory signal.  These results ~~ 
that KIR can not only inhibit cytolytic activity, but can also negatively regulate T  ceil receptor 
activation events that lead to downstream gene activation, and further supports a model that 
implicates PTP1C as a mediator in the KI~ inhibitory signal. 
"~riller cell inhibitory receptors (KIR), a growing hmiIy 
1~1,.of receptors that are present on NK cells and on sub- 
sets of  peripheral T cells, inhibit cytolytic activi  W by recog- 
nizing polymorphic MHC class I molecules on target cells 
(1). NK cells, important in innate immune respomes, rec- 
ognize and kill tumor cells,  virus-infected cells,  and cells 
lacking MHC  class  I  antigens.  The  effector functions  of 
NK cells,  cytolytic activity and cytokine secretion, appear 
to be the result of a finely regulated balance between posi- 
tive signals  that initiate  the  response and negative signals 
that inhibit the activated state (1). KIK appear to be impor- 
tant reguhtory molecules of NK cell effector  functions. 
The KIR present on peripheral T  cells also inhibit killing 
of target cells expresfmg art appropriate MHC class I ligand 
(2, 3). Although the positive signals through the antigen re- 
ceptor resulting in T  cell activation are well defined (4), lit- 
de is known about the signals that may regulate the extent 
or degree ofT cell activation. The presence of KilL on T 
cells offers an intriguing candidate for a negative regulatory 
molecule of cytolytic and noncytolytic functions. 
The cytoplasmic tails of the KIR contain the consensus 
motif D/E(x)2YxxL(x)26YxxL (5--7), which is reminiscent 
of  the  irranunoreceptor  tyrosine-based  activation  motif 
(ITAM)  (D/E(x)2YxxL(x)7_sYxxL) present  in  TCtL  and 
BCtL subunits (4). In T  and B cells, the tyrosines (Y) in the 
I~TAM motif become phosplmcyhted atier receptor stim~ 
lation, and they mediate interaction with the Src homolog~f 
2 (SH2) domains of the ZAP-70/Syk ~ma-ly Oflma~em ty- 
rosine kinases fPTK; 8). The tymanes m the c~o~h~r 
region of the KIR nmy ~  be invoked in S/-12 im~ac- 
lions. Recerrdy, a study by Burshtyn et aL (9) showed ffrat 
the KIR p58 can bind to the protein tyrosine phospbatase 
1C  (PTP1C). PTP1C  (SHP-1, HCP, SH-PTPI) is ~ 66- 
kD protein and a member of  the cytoplasmic, SH2 dome- 
containing family of phosphahas~ which im:ludes PTPID 
(SHP-2, Syp, SH-PTP2) and the Dmsold~ protein r 
screw (10). PTP1C has. been shown to become induci~ 
associated  with  the  erythropoietin  receptor  (F4x)P~,, 
Fc'~IIB1, CD22, c-k/t, and the ILL-3  receptor I~ chain as 
stimulation of these receptors (I1-15). Recent stud/es, cor- 
relate the binding of PTPt C  with the negative regt~tior~ 
of  the EpoR and the negative reguhtion ~R-rrte~a~ed 
activation by Fc~/RIIB1  (11,  12). Additionally, mutations 
in  the PTP1C  gene  have been linked to the severe he- 
matopoietic defects in motheaten (me) and motheaten via- 
ble (mev) mice (16-Ig). 
In this report, we study the inhibito~ fnnctmn of the 
KIR  NKBI  m  T  cells.  Transient ~on  os a  CD8t 
NKB1  chimera in  lurk,  at  T  ce~ attowed analyses of the 
structural requirements of NKBI  necessary for the inhibi- 
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mic  region  of  NKB1  inhibited  TClL-mediated  down- 
stream  gene  activation in Jurkat  T  cells,  and  that  tyrosine 
phosphorylation of NKB1  induced an association between 
PTP1C and the chimeric receptor. Also, mutational analy- 
sis of the tyrosines in the KIR consensus motif established 
the  requirement  of phosphotyrosines  for  the  inhibitory 
functions of NKB1 and for association with PTP1C. 
Materials and Methods 
Cells.  Jurkat  cells and Raji  cells were maintained in RPMI 
1640 medium supplemented with 5% FCS, penicillin,  streptomy- 
cin, and glutamine, as previously described  (19). 
Plasmids.  The  CD8/T  construct  was  described  previously 
(19). The CD8/NKB1  plasmid  was made by digesting  CD8/T 
with BgllI and BamH1 and ligating in a cytoplasmic fragment of 
NKB1  (basepairs 1114-1865), in which these  enzyme sites were 
introduced by PCR mutagenesis  or through shuttle  vectors.  A 
BgllI site was created at amino acid (aa) 364/365 (C/R mutation) 
in NKB1. Primers  5' and 3' of the Bsu36 and Espl sites, respec- 
tively, which mutated Y to F, were used to make the F1, F2, and 
FIF2 constructs.  A primer 5' of the Bsu36 site, deleting 18 aa be- 
tween the two Y in the KIR motif, was used to create  the 18-aa 
del  construct.  All  constructs were  sequenced  using  the  Sanger 
dideoxy-nucleotide technique and then  subcloned into the  ex- 
pression  vector pEF  Bos.  The  NFAT-luciferase  reporter  con- 
struct was a generous gift from Dr. G. Crabtree (Stanford Univer- 
sity, Stanford,  CA). 
Transfections, Stimulations, and NFA T-Luciferase assays.  107 Jur- 
kat  cells were  transfected  by electroporation,  as previously de- 
scribed  (20), with 20/~g of the NFAT reporter plasmid  and 40 
~g of the CD8 chimeric plasmids. 24-40 h after transfection,  2 ￿ 
105 cells were aliquoted into 96-well plates  (Coming Glassware, 
Coming, NY) and cultured in a final volume of 90 ~1. The re- 
maining cells were analyzed  by flow cytometry for CD8 surface 
expression. For stimulation,  equal numbers of Raji cells and Strep- 
tococcus enterotoxin D  (SED; Toxin Technology Inc., Sarasota, 
FL) in the concentrations indicated were added to each well. As a 
control for NFAT activation,  cells were stimulated  with 50 ng/ 
nO PMA and 1.0 I~M ionomycin. The average value of the PMA 
and ionomycin stimulation was used as a maximum stimulation 
value. After 6-8 h at 37~  cells were lysed and luciferase activa- 
tion was determined as described  previously (20). Activation for 
each condition was determined in duplicate,  and each experiment 
was repeated at least three times.  The percent maximum stimula- 
tion value achieved with 300 ng/ml SED plus Raji was averaged 
from three independent experiments for each plasmid. 
Antibodies and Flow Cytometry.  4G10,  an  antiphosphotyrosine 
mAb, was purchased from Upstate Biotechnology,  Inc. (Lake Placid, 
NY). Anti-PTP1C is a rabbit anti-mouse serum (generously  pro- 
vided by Dr. J. Schlessinger,  New York University, New York). 
OKT8 mAb recognizes an extracellular  epitope of CD8 and was 
acquired  from American  Type  Culture  Collection  (Rockville, 
MD). Anti-Zap-70 mAb has been described previously (21). FITC- 
conjugated mouse anti-Leu2a  (anti-CD8)  and FITC-conjugated 
mouse IgG1 were purchased from Becton Dickinson & Co. (Moun- 
tain  View,  CA).  For flow cytometry, 5  ￿  105 to  106 cells were 
stained with saturating  concentrations of antibody and then ana- 
lyzed using  a  FACScan  |  (Becton Dickinson),  as previously  de- 
scribed (22). 
Peptides and Peptide-binding  Assays.  The peptides  were synthe- 
sized in a peptide  synthesizer  (Applied  Biosystems,  Inc.,  Foster 
City, CA), as previously described  (21). The peptide sequence is: 
DPQEVT(Y) ITQLNHCVFTQRKITRPSQRPKTPPTDIIVCY) 
2TELPNAESR.  Peptides  were  phosphorylated  as  follows:  P1 
peptide on Y1; P2 peptide on Y2; P1P2 peptide on Y1 and Y2. 
P0 was unphosphorylated. The { peptides  are described  elsewhere 
(21). Peptide precipitation was performed with avidin-conjugated 
beads  (Vector Laboratories,  Burlingame,  CA), as previously de- 
scribed  (21). Methods  for [3SS]methionine biosynthetic labeling 
were described  previously (23). 
Western Blotting and Immunoprecipitation.  2  ￿  107 Jurkat  cells 
were transiently  transfected  with 40 ~g of the CD8/NKB1 or 20 
~g of the FIF2 (plus 20 Ixg pEF Bos with  no insert).  24-40 h 
later,  106 cells were analyzed by flow cytometry for surface CD8 
expression,  and the remaining cells were stimulated  with pervan- 
adate  (10  mM  Na-orthovanadate,  3.36%  H202)  for  10  rain  at 
37~  The cells were then lysed in buffer containing 1% NP-40, 
10 mM Tris  (pH 7.8),  150 mM NaC1, 2 mM EDTA, and pro- 
tease and phosphatase  inhibitors,  as previously described  (20). Ly- 
sates were immunoprecipitated with 2 ~10KT8  ascites or 4 ~1 
anti-PTP1C serum and protein G-Sepharose (Pharmacia, Alameda, 
CA). The precipitates  were separated  by SDS-PAGE and trans- 
ferred to Immobilon-P membranes  (Millipore, Bedford, MA). The 
blots were blocked, as described previously (20) and then incubated 
with primary antibody, followed by secondary step reagent con- 
jugated with horseradish peroxidase  (protein  A-HRP; Amersham, 
Arlington Heights,  IL) or goat anti-mouse IgG-HRP (Southern 
Biotechnology Associates, Birmingham, AL).  Proteins were de- 
tected by enhanced chemiluminescence (ECL kit; Amersham). 
Results  and Discussion 
PTPI C-1 Associates with Doubly Tyrosine-phosphorTlated KIR 
Peptides.  To  identify  proteins  associated  with  the  cyto- 
plasmic region of the KIR that may be involved in signal 
transduction, we generated biotinylated peptides correspond- 
ing to  the  KIR consensus  motif of NKAT1  (aa  295-341 
[5])  and  used  these  peptides  to  precipitate  proteins  from 
metabolically  labeled  ceils.  The  peptides  were  either  un- 
phosphorylated (P0)  or, phosphorylated on the first (mem- 
brane  proximal)  (P1),  the  second  (carboxy-terminal)  (P2), 
or  both  tyrosines  (P1P2).  Only  the  PlP2  peptide  was 
found to bind to a distinct 66-kD band in 3SS-metabolicaily 
labeled lysates from Jurkat ceils  (data not shown). Western 
blot  analyses  using  antisera  against  known  SH2  domain- 
containing proteins in this molecular mass range identified 
PTP1C as one 66-kD protein that could bind to the dou- 
bly  phosphorylated  peptide  (Fig.  1).  The  P1P2  peptide 
bound to PTP1C in a dose-dependent manner.  Conversely, 
the  doubly phosphorylated  ~  peptide  bound  to  ZAP-70, 
but not to PTP1C,  confirming the specificity of the inter- 
action.  Phosphorylation of both tyrosines was required for 
in vitro binding,  since the single phosphotyrosine peptides 
did not bind to PTP1C. Therefore, PTP1C associated with 
the doubly tyrosine phosphorylated KIR peptide but not to 
the  unphosphorylated  or  singly  tyrosine  phosphorylated 
peptides. 
These peptide binding study results differ from those by 
Burshtyn et al.,  who showed PTP1C association with sin- 
gle phosphotyrosine  peptides  (9).  This  may represent  dif- 
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cell lysates from unstimulated Jurkat cells were mixed with the indicated 
biotinylated peptides, p~ is a doubly tyrosine-phosphorylated  ~ITAM pep- 
tide. ~ is an unphosphorylated  ~ITAM peptide. The ~ peptides  are described 
elsewhere (21). The remaining peptides are based on the NKAT1 KIP. 
motif,  DPQEVT(Y) 1TQLNHCVFTQP`KITP`PSQP`PKTPPTDIIV- 
(Y)2TELPNAESP`. P0 is unphosphorylated. P1, P2, and P1P2 are phos- 
phorylated on  the  first, second, and both tyrosines, respectively. The 
amount of peptide is given in micrograms. Peptides were isolated with 
avidin-conjugated beads, and the complexes were analyzed by immuno- 
blot analysis  with the antibodies shown on the left. Lysates from 4.5  ￿ 
107 cells were used for each peptide and samples  were split and loaded on 
two separate gels. Whole-cell lysate (WCL) on the left is a positive con- 
trol for the protein  detected by the antibody. Avidin-conjugated beads 
(BEADS) with no peptide is shown on the fight. 
ferences in the peptide-binding assays. For example, Bursh- 
tyn et al. used peptides covalendy conjugated to Affi-gel 10 
containing  only  a  partial KIP,. p58  consensus  motif.  The 
high  local  concentration  of  the  phosphorylated  peptide 
bound to Am-gel 10  may have facilitated detection of the 
interaction  and  involved  both  SH2  domains  binding  to 
multiple peptides.  However,  the  solution binding  studies 
reported  here  show  that  a  high  affinity interaction  is  fa- 
vored  when  both  tyrosines  of a  single  KIP,  peptide  are 
phosphorylated. 
PTP1C Associates with  the  Cytoplasmic  Region  of NKB1. 
To  further  study the  mechanisms  by which  NKB1  medi- 
ates negative signaling in T  cells and whether this involves 
PTPIC  binding,  we  constructed  a  CD8/NKB1  chimeric 
expression vector.  This construct,  containing the extracel- 
lular and transmembrane region of the CD8  molecule and 
the  intracellular  region  of NKB1,  was  transiently  trans- 
fected into Jurkat  T  cells. We  also mutated  the  first  (F1), 
the second (F2), or both tyrosines to phenylalanine (F1F2) 
in the KIR consensus motif of NKBI  (Fig. 2 A) and trans- 
fected these into Jurkat cells. 
The transfected cells were stimulated with pervanadate, a 
phosphatase inhibitor that induces maximal tyrosine phos- 
phorylation (24), lysed, and the CD8/NKB1  chimera pro- 
teins precipitated. The CD8/NKB1  proteins were resolved 
by SDS-PAGE and blotted with anti-PTPIC. As shown in 
Fig.  2  B  (upper panel),  PTPIC  associated with  the  CD8/ 
NKB1  chimera  expressed  in Jurkat  T  cells  after  tyrosine 
phosphorylation of NKB1  by pervanadate. Despite a higher 
expression level, the mutant lacking both tyrosines (F1F2), 
did not associate with PTP1C.  Stripping and reblotting the 
wild-type CD8/NKB1  chimera protein with an antiphos- 
photyrosine mAb 4G10 demonstrated a 40-kD phosphory- 
Figure 2.  PTP1C  binds to the phosphorylated CD8/NKB1  chimera. 
(A) Amino acid sequence of the cytoplasmic region of NKB1 highlight- 
ing tyrosines in the KIP. motif that were mutated. F1 mutated the first Y 
to  F, F2 the second, Y  and FIF2 mutated both.  18-aa del deleted  18 
amino acids between the two tyrosines. (B) Jurkat T cells  were transfected 
with  plasmids encoding  CD8/NKB1  or the  F1F2 mutant.  40  h  after 
transfection, cells  were left either unstimulated or stimulated  with pervana- 
date for 10 min and then  lysed. The lysates were  immunoprecipitated 
with anti-CD8  (OKTS) and blotted with anti-PTP1C  (upperpane  O. The 
blot  was  then  stripped  and  reblotted  with  antiphosphotyrosine mAb 
(4GIO; lower  panel). The  arrow corresponds to the chimera. Each lane 
represents 4.5  ￿  107 cells. CD8 surface expression for CD8/NKB1  and 
F1F2 were  5  and  41%  positive  cells, respectively. Whole-cell  lysates 
(WCL) representing 106 cells are shown on the fight. Similar results with 
equivalent tyrosine phosphorylation patterns were seen in three other ex- 
periments. 
lated protein in the pervanadate-stimulated cell lysate, con- 
sistent with the migration of the chimera protein (Fig. 2  B, 
lower panel).  Similarly, the  CD8/NKB1  chimera  was  de- 
tected  in  PTP1C  immunoprecipitates  (data  not  shown). 
Therefore, the phosphotyrosines in the KIP, motif of NKB1 
are necessary for PTP1C  association. These results are con- 
sistent with the  in vitro peptide-binding studies presented 
above, 
The  Cytoplasmic Domain of NKB1  Is  Capable of Inhibiting 
TCR Activation.  The  in vivo transient  expression system 
described above also allowed us to assess  the functional ef- 
fect  of NKB1  expression on  TCR.-mediated  signal trans- 
duction.  Activation  through  the  TCR  was  achieved  by 
stimulation with  the  superantigen,  SED,  presented by the 
Raji B  cell line, and was monitored by transcriptional acti- 
vation of the NFAT-luciferase reporter. As shown in Fig. 3 
A, we observed a striking inhibition in NFAT activation in 
T  cells  expressing  the  chimera  containing  NKB1  when 
compared to  a  truncated  CD8  molecule  (CD8/T).  Thus, 
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TCR-mediated  downstream  gene  activation  in Jurkat  T 
cells. NKB1  has also bee** implicated in the negative regu- 
lation of IFN-~/and TNF-a  product/o** in  NKB1 + T  cell 
clones (25). Therefore, NKB1  appears to regulate both cy- 
tolytic and nonqm~ytic effector functions in T  ceils. 
Inhibition by Nt~t  Is Me~'ated  by the Tyrosines in the KIR 
Consensus Motif.  To  further  study  the  structural  impor- 
tance  of  phosphotyrosines  in  the  inhibitory  signal  of 
NKB1,  we  transiendy expressed the  tyrosine mutant  con- 
structs (Fig. 2 A) and assessed their ability to inhibit TCg- 
mediated  NFAT  activat~or,.  The  mutation  of  both  ty- 
rosmes (F1F2) completely abolished the mhl~dtory effect of 
NKB1  (Fig. 3  B). This effect was not ca~tsed by expression 
levels because the F1F2 mutant was present at much higher 
levels  than  the  CD8/NKBi  chimera,  based  on  flow cy- 
tometry atmtysis. Therefore, loss ofiahibition must be a con- 
sequence of the tyrosme matatioas. The 1ms ofinkibition by 
the F1F2 mutam correlates with the ahse~e of PTP1C  as- 
sociation demonstrated in Fig. 2. Therefore, PTP1C is likely 
to  be  important  in  mediating  the  inhibitory  signal  of the 
NKB1  KIR. 
Subsequent  analysis  of the  single  tyrosine  mutants,  FI 
and  F2,  suggest  that  the  tyrosines may  have  different  de- 
grees  of impoct~ce  in  the  mhibitea-y signal  mediated  by 
NKBI.  The  F2  rmitant  inhibited  NFAT  actiwtion  to  a 
simitar degree as the wild-type CD~NKBI  dmrg'ra, whereas 
the  F1  nmtam ~  it to a  m~ch Jesser extent (~--~5~A 
OfCD8/NKB1).  Th~  both tyrosines omatrib~e to the in- 
hibitory effect, ~ut ttte first tyromae (mem~a~e t~roximal) 
appears  crtacial. Interestingly, B~tsht~  et  ,1.  (9)  found  a 
greater ~t  OfPTP1 C,mzyme ac0vi~ with a phos-- 
phorytated i~eptide containing the fiu,  t qrrosine [pY1) from 
the KIR  motif dam wirk a  peptide contmmng the second 
tyrosine  (pY2).  The  difference  in  inhibition  between  F1 
and F2 detected in our in vivo assay may reflect either dif- 
ferential binding to  PTP1 C  or differences in  phosphatase 
activation. 
The  KIR  consensus motif is very similar to  the  ITAM 
motif present  in  TCR  and  BCR  subunits.  The  two  ty- 
rosines in the ITAM motif are important for ZAP-70/Syk 
binding (8). In the crystal structure of ZAP-70 bound to a 
phosphorytatext peptide,  the  SH2  domains  are  in  a  fixed 
position and oriented in such a way as to place strict spatial 
constraints on the spacing between tyrosines in the  ITAM 
(26).  We  tested  whether  the  tyrosines  in  the  KIR  motif 
Figure 3.  Inhibition of superantigen-induced Jurkat activation by the 
CD8/NKBI chimera is dependent on cytoplasmic  tyrosines. (A)Jurkat T 
cells were cotramFected  with plasmids  encoding CD8/T or CD8/NKBI 
and NFAT-luciferase. Transfected cells were stimulated with equal num- 
bers of Raji cells plus SED at the concentrations indicated and then as- 
sayed for luciferase  activity. The results are shown as the percent of PMA 
plus ionomycin mmulation. PMA #us ionomycin values for CD8/T and 
CD8/NKBI  were  40,602, and  120,675 light units, respectively. CD8 
surface expre~on leve~ for CD8/T and CD8/NKB1  were 25 and 12% 
positive cells, respectively. --~3-, CD8/T;  +,  CD8/NKB.1.  (B)Jur- 
kat T cells were cotransfected  with NFAT-luciferase and plasmids  encod- 
ing CD8/T, CD8/NKB1,  FI, F2, F1F2, and 18-aa del. Transfected cells 
were then stimulated with R.aji cells and SED in the concentrations ira]i- 
cared and assayed  for luciferase  activity. The results are shown as percent 
of PMA plus ionomycin  stimulation. PMA plus ionomycin values for 
CD8/T, CD8/NKB1,  F1, F2, FIF2, and 18-aa del were 78,358, 116,664, 
141,725, 131,383, 79,636, and 78,840 light units, respectively. The per- 
cent of  CD8--positive  cells  were: CD8/T, 33%; CDS/NKB1, 9~  F1, 33%; 
F2, 22%; FIF2, 30~  and 18-aa del, 23%. Vector without insert gave lu- 
ciferase activity that was 25--50~  higher than  CD8/T.  ~,  CD8/T; 
--O--, CD8/NKB.1;  -~--, F1;  --~-, F2; --{~--, F1F2; - "O- -, 18-aa del. 
A and B each represent individual experiments. (C) The results are ex- 
pressed as the mean ma.xamum sttmulation from three independent exper- 
iments (300 ng/ml SED). Error bars represent SD fi'om the mean. 
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leted  18  amino  acids  between  the  two  tyrosines  in  the 
NKB1  KIR motif (Fig.  2 A) and tested the mutant for its 
abihty to inhibit TCR-mediated NFAT activation. As Fig. 
3  B demonstrates,  the expression of this mutant (18-aa del) 
inhibited  NFAT activation to the same degree as the wild- 
type CD8/NKB1  chimera.  Thus,  altering the  spacing be- 
tween tyrosines did not affect the inhibitory effect ofNKB1, 
suggesting that the spacing is not essential in the protein in- 
teractions  that mediate  inhibition.  The crystal structure  of 
the  SH2  domains  of the  related  PTP  PTP1D  bound  to 
phosphotyrosine  peptides  may  offer  an  explanation  for 
these  findings.  The  SH2  domains  of PTPID  are  fixed  in 
orientation, like the ZAP-70 SH2 domains, but in contrast 
to  ZAP-70,  they  are  oriented  such  that  the  phosphoty- 
rosine  peptides  are  roughly  antiparalleI  relative  to  each 
other  (27).  This  suggests that the  binding of the  SH2  do- 
mains  of PTPID  and  related  phosphatases  like  PTPIC  to 
phosphotyrosines may not occur in tandem,  like ZAP-70, 
but  on  two  separate  proteins  in  trans. Thus,  alteration  of 
the  spacing between  the  two  tyrosines  in  the  KIR  motif 
might not affect PTPIC binding. 
In summary, we demonstrate  that expression  of the  cy- 
toplasmic domain of the KIR NKB1 in a chimeric receptor 
inhibits TCK-mediated downstream gene activation in Jur- 
kat  T  cells.  Tyrosine  phosphorylation  of the  NKB1  chi- 
mera  in Jurkat  cells  induced  association  between  PTP1C 
and  the  chimeric  receptor.  Mutations  of both  tyrosines 
abolished the ability of NKB1  to both inhibit TCR  activa- 
tion  and  to  bind  PTP1C.  The  in  vitro  peptide-binding 
studies suggest that optimal binding of PTP1C to the KItK 
motif occurs when both tyrosines are phosphorylated. How- 
ever,  the single  tyrosine mutants  (F1  or F2)  retained  their 
ability  to  inhibit  TCK  activation,  suggesting that  PTP1C 
association  with  KI1K proteins  may  occur  in  cis  or  trans. 
The  membrane-proximal  tyrosine  plays  a  crucial  role  in 
mediating the  inhibitory signal.  In contrast to the tyrosine 
mutations,  alteration  of the  spacing between  tyrosines  in 
the KIP, consensus motif did not affect the inhibitory sig- 
nal. These results support a model in which PTP1C plays a 
role in mediating the negative signal transmitted by NKB1 
and are consistent with studies  by Burshtyn  et al.  (9).  Fu- 
ture  studies  on the  targets  of NKB1  will  further clarify its 
role in modulating TCR-mediated signals. 
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